vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $16.9M, roughly 1.3× FVCBankcorp, Inc.). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
AUTL vs FVCB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $16.9M |
| Net Profit | $-79.1M | — |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 43.7% |
| Net Margin | -373.3% | — |
| Revenue YoY | — | 4377.5% |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $16.9M | ||
| Q3 25 | $21.2M | $416.0K | ||
| Q2 25 | $20.9M | $15.8M | ||
| Q1 25 | $9.0M | $382.0K | ||
| Q4 24 | — | $378.0K | ||
| Q3 24 | $0 | $412.0K | ||
| Q2 24 | $0 | $415.0K | ||
| Q1 24 | $10.1M | $359.0K |
| Q4 25 | — | — | ||
| Q3 25 | $-79.1M | $5.6M | ||
| Q2 25 | $-47.9M | $5.7M | ||
| Q1 25 | $-70.2M | $5.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-82.1M | $4.7M | ||
| Q2 24 | $-58.3M | $4.2M | ||
| Q1 24 | $-52.7M | $1.3M |
| Q4 25 | — | 43.7% | ||
| Q3 25 | -337.9% | — | ||
| Q2 25 | -292.6% | 45.9% | ||
| Q1 25 | -726.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -384.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | -373.3% | 1341.1% | ||
| Q2 25 | -229.0% | 36.0% | ||
| Q1 25 | -781.1% | 1352.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1133.3% | ||
| Q2 24 | — | 1001.2% | ||
| Q1 24 | -522.1% | 373.3% |
| Q4 25 | — | $0.31 | ||
| Q3 25 | $-0.30 | $0.31 | ||
| Q2 25 | $-0.18 | $0.31 | ||
| Q1 25 | $-0.26 | $0.28 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | $-0.31 | $0.25 | ||
| Q2 24 | $-0.22 | $0.23 | ||
| Q1 24 | $-0.24 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $253.6M |
| Total Assets | $661.9M | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $253.6M | ||
| Q3 25 | $265.5M | $249.8M | ||
| Q2 25 | $346.5M | $243.2M | ||
| Q1 25 | $371.1M | $242.3M | ||
| Q4 24 | — | $235.4M | ||
| Q3 24 | $477.0M | $230.8M | ||
| Q2 24 | $527.8M | $226.5M | ||
| Q1 24 | $582.0M | $220.7M |
| Q4 25 | — | $2.3B | ||
| Q3 25 | $661.9M | $2.3B | ||
| Q2 25 | $721.0M | $2.2B | ||
| Q1 25 | $746.3M | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $827.5M | $2.3B | ||
| Q2 24 | $853.6M | $2.3B | ||
| Q1 24 | $901.4M | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $23.9M |
| Free Cash FlowOCF − Capex | $-72.3M | $23.8M |
| FCF MarginFCF / Revenue | -341.2% | 140.7% |
| Capex IntensityCapex / Revenue | 20.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $40.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.9M | ||
| Q3 25 | $-67.9M | $7.6M | ||
| Q2 25 | $-72.8M | $3.3M | ||
| Q1 25 | $-75.6M | $5.4M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | $-76.7M | $4.7M | ||
| Q2 24 | $-51.1M | $1.6M | ||
| Q1 24 | $-40.5M | $7.2M |
| Q4 25 | — | $23.8M | ||
| Q3 25 | $-72.3M | $7.6M | ||
| Q2 25 | $-80.1M | $3.3M | ||
| Q1 25 | $-83.8M | $5.4M | ||
| Q4 24 | — | $18.1M | ||
| Q3 24 | $-86.3M | $4.6M | ||
| Q2 24 | $-51.9M | $1.5M | ||
| Q1 24 | $-41.0M | $7.1M |
| Q4 25 | — | 140.7% | ||
| Q3 25 | -341.2% | 1818.0% | ||
| Q2 25 | -382.6% | 20.8% | ||
| Q1 25 | -933.1% | 1413.6% | ||
| Q4 24 | — | 4786.0% | ||
| Q3 24 | — | 1121.8% | ||
| Q2 24 | — | 361.2% | ||
| Q1 24 | -406.8% | 1988.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 20.8% | 0.2% | ||
| Q2 25 | 34.8% | 0.1% | ||
| Q1 25 | 91.8% | 4.2% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 14.1% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | 5.3% | 3.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
